Vistin Pharma ASA: Invitation to Q3 2023 conference call
October 18 2023 - 7:00AM
Vistin Pharma ASA: Invitation to Q3 2023 conference call
Oslo, Norway, 18 October 2023
Vistin Pharma ASA will release its third quarter results on
Wednesday 25th of October 2023. Vistin Pharma will host a
conference call for all shareholders and interested parties at the
same day; Wednesday 25th of October at 08:30 CET. There will
be a Q&A session following the management discussion.
The conference call will be held in English.
The third quarter conference call will be available via web and
audio through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/bbzmgojv
Telephone conference
(online
registration):
https://register.vevent.com/register/BIde003424d0984dc899edfd078e0f4dd9
*****
For further information, please contact:
Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing
Metformin Hydrochloride (API). The Metformin is also available as
Direct Compressible lubricated granules. As a solely dedicated
European Metformin producer, Vistin Pharma is a well-positioned
supplier to leading pharmaceutical companies. Vistin Pharma is
headquartered in Oslo, Norway, and has highly qualified employees
and a dedicated manufacturing facility in Kragerø.
Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart
From Oct 2023 to Oct 2024